Roivant Sciences President Eric Venker Sells and Buys Shares Amid Market Volatility

Roivant Sciences Ltd., with ticker symbol ROIV, recently disclosed that its President and Immunovant CEO, Eric Venker, executed a transaction involving the sale of 200,000 shares at a price of $21.92 per share on January 12, 2026. Furthermore, Venker acquired an additional 200,000 shares at a purchase price of $3.85 per share on the same date.